WO2006026592A3 - Oral administration of poorly absorbed drugs, methods and compositions related thereto - Google Patents

Oral administration of poorly absorbed drugs, methods and compositions related thereto Download PDF

Info

Publication number
WO2006026592A3
WO2006026592A3 PCT/US2005/030774 US2005030774W WO2006026592A3 WO 2006026592 A3 WO2006026592 A3 WO 2006026592A3 US 2005030774 W US2005030774 W US 2005030774W WO 2006026592 A3 WO2006026592 A3 WO 2006026592A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug
poorly absorbed
absorbed drugs
methods
oral administration
Prior art date
Application number
PCT/US2005/030774
Other languages
French (fr)
Other versions
WO2006026592A2 (en
Inventor
Edith Mathiowitz
Avinash Nangia
Jules S Jacob
Mark R Kreitz
Rebecca Doane
Ryan Donnelly
Original Assignee
Spherics Inc
Edith Mathiowitz
Avinash Nangia
Jules S Jacob
Mark R Kreitz
Rebecca Doane
Ryan Donnelly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/604,991 priority Critical
Priority to US60520004P priority
Priority to US60520104P priority
Priority to US60499004P priority
Priority to US60519904P priority
Priority to US60499104P priority
Priority to US60519804P priority
Priority to US60/605,199 priority
Priority to US60/604,990 priority
Priority to US60/605,198 priority
Priority to US60/605,200 priority
Priority to US60/605,201 priority
Priority to US60/607,905 priority
Priority to US60790504P priority
Priority to US11/009,327 priority
Priority to US11/009,327 priority patent/US20050201974A1/en
Priority to US60/635,812 priority
Priority to US63581204P priority
Priority to US60/650,375 priority
Priority to US65019105P priority
Priority to US65037505P priority
Priority to US60/650,191 priority
Priority to US11/072,098 priority
Priority to US11/072,098 priority patent/US20050249799A1/en
Priority to US60/676,383 priority
Priority to US67638305P priority
Application filed by Spherics Inc, Edith Mathiowitz, Avinash Nangia, Jules S Jacob, Mark R Kreitz, Rebecca Doane, Ryan Donnelly filed Critical Spherics Inc
Publication of WO2006026592A2 publication Critical patent/WO2006026592A2/en
Publication of WO2006026592A3 publication Critical patent/WO2006026592A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5138Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5161Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes

Abstract

The invention provides methods and compositions for the delivery of poorly absorbed drugs. In some embodiments, the drug is administered in the form of microparticles or nanoparticles. In other embodiments, the drug is encapsulated with polymer. In certain embodiments, the drug is administered in combination with an absorption enhancer. The invention further relates to dosing schedules to maintain the oral bioavailability of poorly absorbed drugs, such as paclitaxel. In another embodiment, the method involves administering inhibitors of one or more inhibitors of a drug efflux pump in combination with a poorly absorbed drug.
PCT/US2005/030774 2003-12-09 2005-08-29 Oral administration of poorly absorbed drugs, methods and compositions related thereto WO2006026592A2 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
US60520004P true 2004-08-27 2004-08-27
US60520104P true 2004-08-27 2004-08-27
US60499004P true 2004-08-27 2004-08-27
US60519904P true 2004-08-27 2004-08-27
US60499104P true 2004-08-27 2004-08-27
US60519804P true 2004-08-27 2004-08-27
US60/605,199 2004-08-27
US60/604,990 2004-08-27
US60/605,198 2004-08-27
US60/605,200 2004-08-27
US60/605,201 2004-08-27
US60/604,991 2004-08-27
US60790504P true 2004-09-08 2004-09-08
US60/607,905 2004-09-08
US11/009,327 US20050201974A1 (en) 2003-12-09 2004-12-09 Bioadhesive polymers with catechol functionality
US11/009,327 2004-12-09
US63581204P true 2004-12-13 2004-12-13
US60/635,812 2004-12-13
US65019105P true 2005-02-04 2005-02-04
US65037505P true 2005-02-04 2005-02-04
US60/650,191 2005-02-04
US60/650,375 2005-02-04
US11/072,098 US20050249799A1 (en) 2004-03-03 2005-03-03 Polymeric drug delivery system for hydrophobic drugs
US11/072,098 2005-03-03
US67638305P true 2005-04-29 2005-04-29
US60/676,383 2005-04-29

Publications (2)

Publication Number Publication Date
WO2006026592A2 WO2006026592A2 (en) 2006-03-09
WO2006026592A3 true WO2006026592A3 (en) 2006-09-14

Family

ID=35703588

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/030774 WO2006026592A2 (en) 2003-12-09 2005-08-29 Oral administration of poorly absorbed drugs, methods and compositions related thereto

Country Status (1)

Country Link
WO (1) WO2006026592A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911777B2 (en) 2007-04-04 2014-12-16 Sigmoid Pharma Limited Pharmaceutical composition of tacrolimus
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
CN105101950A (en) * 2013-03-05 2015-11-25 安特里斯生物制药公司 Pharmaceuticals for oral delivery
US9220681B2 (en) 2012-07-05 2015-12-29 Sigmoid Pharma Limited Formulations
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077309A1 (en) * 2005-09-30 2007-04-05 Wong Patrick S Banded controlled release nanoparticle active agent formulation dosage forms and methods
US20100239665A1 (en) * 2007-05-01 2010-09-23 Ivan Coulter Pharmaceutical nimodipine compositions
JP5537425B2 (en) 2007-06-26 2014-07-02 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. Lyophilized antifungal composition
US9089544B2 (en) 2007-08-24 2015-07-28 Slotervaart Participaties Bv Composition
KR101544498B1 (en) * 2007-08-24 2015-08-17 스티칭 허트 네덜란드 칸커 인스티튜트 Compositions for the treatment of neoplastic diseases
BR112012002963A2 (en) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd immunomodulatory compositions comprising a polymer matrix and an oily phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
US9833411B2 (en) 2015-01-12 2017-12-05 Enteris Biopharma, Inc. Solid oral dosage forms

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228399B1 (en) * 1996-08-22 2001-05-08 Research Triangle Pharmaceuticals Composition and method of preparing microparticles of water-insoluble substances
US6322817B1 (en) * 1999-02-17 2001-11-27 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US20020013271A1 (en) * 1996-08-22 2002-01-31 Indu Parikh Cyclosporiine particles
US6391335B1 (en) * 1998-04-29 2002-05-21 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6228399B1 (en) * 1996-08-22 2001-05-08 Research Triangle Pharmaceuticals Composition and method of preparing microparticles of water-insoluble substances
US20020013271A1 (en) * 1996-08-22 2002-01-31 Indu Parikh Cyclosporiine particles
US6391335B1 (en) * 1998-04-29 2002-05-21 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6322817B1 (en) * 1999-02-17 2001-11-27 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911777B2 (en) 2007-04-04 2014-12-16 Sigmoid Pharma Limited Pharmaceutical composition of tacrolimus
US9114071B2 (en) 2007-04-04 2015-08-25 Sigmoid Pharma Limited Oral pharmaceutical composition
US9387179B2 (en) 2007-04-04 2016-07-12 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US9585844B2 (en) 2007-04-04 2017-03-07 Sigmoid Pharma Limited Oral pharmaceutical composition
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
US9402788B2 (en) 2007-04-26 2016-08-02 Sigmoid Pharma Limited Manufacture of multiple minicapsules
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
US9220681B2 (en) 2012-07-05 2015-12-29 Sigmoid Pharma Limited Formulations
CN105101950A (en) * 2013-03-05 2015-11-25 安特里斯生物制药公司 Pharmaceuticals for oral delivery

Also Published As

Publication number Publication date
WO2006026592A2 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
Heresco-Levy et al. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis
Illum Nasal drug delivery—recent developments and future prospects
JO2932B1 (en) Pegylated insulin lispro compounds
RU2470016C2 (en) Bipirazole derivative
BRPI0806313A2 (en) anti-IL-13 antibody formulation; aerosol formulation of an anti-IL-13 antibody; formulaçãoliofilizada of an anti-IL-13 antibody; A pharmaceutical composition for the treatment of a disorder related to IL-13; manufacturing a pharmaceutical composition; a method of treating a disorder related to IL-13; Injection syringe; Device for nasal administration; transdermal patch; intravenous bag; Kit comprising at least one container; kit; and prefilled injectable syringe
IL217153D0 (en) Controlled release formulations
IL220480A (en) 1-benzyl-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors, preparation method thereof, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
RU2487713C2 (en) Pharmaceutical composition and method of treating or preventing physiological and/or pathophysiological conditions associated with pi3k kinase inhibition in mammals
CA2546321A1 (en) Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
AR039744A1 (en) Methods and dosage forms to increase solubility of drug compositions for controlled administration
WO2007130491A3 (en) Patient customized therapeutic regimens
NO336161B1 (en) Medication delivery device which prevents further dose preparation after administration of the last dose.
CA2451106A1 (en) Sequential drug delivery systems
WO2004024209A3 (en) Materials and methods for drug delivery and uptake
AR088875A1 (en) Oral pharmaceutical dosage form of tamperproof
TWI636809B (en) Drug delivery device and method of manufacturing the drug delivery device
WO2006108405A3 (en) Nanoparticle/active ingredient conjugate
EP1542903A4 (en) Packaging and dispensing of rapid dissolve dosage form
EP1804765A4 (en) Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2005016423A3 (en) Delivery devices
CA2526616A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
RU2014132563A (en) The combination of an insulin agonist and glp-1
EP2708256A3 (en) Device and method for delivery of a medicament
WO2006039336A3 (en) Conveniently implantable sustained release drug compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase